
Opinion|Videos|May 21, 2025
Q&A: Revenue Impact and Clinical Service Expansion Opportunities
Author(s)Duane Jones, BS Pharm
A panelist discusses how point-of-care testing can increase pharmacy revenue through the tests themselves and related OTC product recommendations, and by attracting new patients who were not previously customers.
Advertisement
Episodes in this series

Q&A – Business Impact and Future Opportunities
Main Discussion Topics:
- Revenue impact of point-of-care testing
- Opportunities for complementary product recommendations
- Future evolution of pharmacy clinical services
Key Points for Physicians:
- Point-of-care testing creates opportunities for appropriate OTC product recommendations
- Testing services often attract patients not previously using the pharmacy
- Testing programs can expand into additional clinical services such as contraceptive prescribing
Notable Insights:
- Primary revenue comes from testing services rather than subsequent product sales
- Word-of-mouth referrals from satisfied patients drive program growth
- Testing programs position pharmacies for future value-based care opportunities
Clinical Significance:
As health care payment models transition from fee-for-service to value-based reimbursement, point-of-care testing represents a strategic pathway for community pharmacies to establish clinical service infrastructure supporting long-term sustainability and expanded health care access.
Advertisement
Related to this article

Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.

In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.

Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.

In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.

A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.

In part 2 of our pre-election series, detailing key health policies for pharmacists at this year’s midterms, a legal expert touches on MFN pricing, ACA subsidies, and more.

Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Protocol Is Linked With More Same-Day Vaccine Coadministration
2
FAQ: Policies for Pharmacists to Track Heading into 2026 Midterms
3
Cost-Plus Pricing Reshapes Pharmacy, But Savings Are Not Guaranteed
4
Integrated Care and the Keys to Successful GLP-1 Therapy
5


